Duration of anticoagulation for upper extremity deep vein thrombosis associated with cancer and central venous catheter: Outcome of a cohort study

Bleker, 2016, Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review, Thromb Res, 140, S81, 10.1016/S0049-3848(16)30104-9 Kucher, 2011, Clinical practice. Deep-vein thrombosis of the upper extremities, N Engl J Med, 364, 861, 10.1056/NEJMcp1008740 Grant, 2012, Diagnosis and management of upper extremity deep-vein thrombosis in adults, Thromb Haemost, 108, 1097, 10.1160/TH12-05-0352 Couban, 2005, Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer, J Clin Oncol, 23, 4063, 10.1200/JCO.2005.10.192 Kang, 2017, Peripherally inserted central catheter-related vein thrombosis in patients with lung cancer, Clin Appl Thromb Hemost, 23, 181, 10.1177/1076029615595880 Jiang, 2020, Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: a systematic review and meta-analysis, J Thromb Haemost JTH, 18, 2253, 10.1111/jth.14930 Verso, 2003, Venous thromboembolism associated with long-term use of central venous catheters in cancer patients, J Clin Oncol, 21, 3665, 10.1200/JCO.2003.08.008 Farge, 2016, International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer, Lancet Oncol, 17, e452, 10.1016/S1470-2045(16)30369-2 Zwicker, 2014, Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH, J Thromb Haemost JTH, 12, 796, 10.1111/jth.12527 Debourdeau, 2013, International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer, J Thromb Haemost JTH, 11, 71, 10.1111/jth.12071 Kearon, 2016, Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report, Chest, 149, 315, 10.1016/j.chest.2015.11.026 Sanchez, 2019, [Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version], Rev Mal Respir, 36, 249, 10.1016/j.rmr.2019.01.003 Rafii, 2020, Management of cancer-related thrombosis in the era of direct oral anticoagulants: a comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC), J Med Vasc, 45, 28 Carrier, 2012, Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis, J Thromb Haemost JTH, 10, 2599, 10.1111/jth.12028 Schulman, 2005, Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients, J Thromb Haemost JTH, 3, 692, 10.1111/j.1538-7836.2005.01204.x Kearon, 2012, Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, e419S, 10.1378/chest.11-2301 Delluc, 2015, Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients, Thromb Res, 135, 298, 10.1016/j.thromres.2014.11.020 Lee, 2003, Venous thromboembolism and cancer: risks and outcomes, Circulation, 107, I17, 10.1161/01.CIR.0000078466.72504.AC Sørensen, 2000, Prognosis of cancers associated with venous thromboembolism, N Engl J Med, 343, 1846, 10.1056/NEJM200012213432504 Tran, 2010, Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters, Leuk Lymphoma, 51, 1473, 10.3109/10428194.2010.481065 King, 2006, Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients, South Med J, 99, 1073, 10.1097/01.smj.0000240707.22171.12 Ong, 2006, Peripherally inserted central catheters and upper extremity deep vein thrombosis, Australas Radiol, 50, 451, 10.1111/j.1440-1673.2006.01623.x Agnelli, 2020, Apixaban for the treatment of venous thromboembolism associated with cancer, N Engl J Med, 382, 1599, 10.1056/NEJMoa1915103 Porfidia, 2020, Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience, J Thromb Thrombolysis, 50, 355, 10.1007/s11239-020-02044-4 Schastlivtsev, 2019, Rivaroxaban in the treatment of upper extremity deep vein thrombosis: a single-center experience and review of the literature, Thromb Res, 181, 24, 10.1016/j.thromres.2019.07.008 Davies, 2018, A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2), Thromb Res, 162, 88, 10.1016/j.thromres.2017.04.003